Benzinga | Oct 21, 2020 06:09AM EDT

HC Wainwright & Co. Maintains Buy on Anavex Life Sciences, Raises Price Target to $14

HC Wainwright & Co. maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and raises the price target from $12 to $14.